TheraCryf PLC (TCF)
Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
0.70p
Buy
0.80p
-0.03p (-4.00%)
Prices updated at 09 May 2024, 12:31 BST
| Prices minimum 15 mins delay
Prices in GBX
Evgen Pharma PLC is a clinical stage drug development company focused on cancer and neurological disease. Its pipeline is based on Sulforadex technology which includes synthetic and stabilized analogues of sulforaphane.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
0.75
0.00 (+0.00%)
Today open
0.75
-0.03 (-4.00%)
Today, 12:31:56 BST
0.72
0.72p - 0.72p | |
4.05p - 0.70p | |
- | |
3.21m | |
- | |
75,000 | |
7,200 | |
0.81 | |
774,229.74 | |
1.98 | |
274.89m | |
GB00BSVYN304 | |
-0.01 | |
- |
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.